Sab Biotherapeutics Stock Forecast

Buy candidate since Jul 30, 2026 Gain 42.86%

The Sab Biotherapeutics, Inc. stock price gained 42.86% on the last trading day (Friday, 31st Jul 2026), rising from $0.0140 to $0.0200. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 266.92% from a day low at $0.0130 to a day high of $0.0477. The price has been going up and down for this period, and there has been a 23.46% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 540 thousand more shares were traded than the day before. In total, 585 thousand shares were bought and sold for approximately $11.71 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.0220 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -29.43% during the next 3 months and, with a 90% probability hold a price between $0.0053 and $0.0155 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

SABSW Signals & Forecast

The Sab Biotherapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0129 and $0.0129. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, July 28, 2026, and so far it has risen 153.16%. Further rise is indicated until a new top pivot has been found. Sab Biotherapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Sab Biotherapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0168 and $0.0164. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Sab Biotherapeutics, Inc. finds support just below today's level at $0.0168. If this is broken, then the next support from accumulated volume will be at $0.0164 and $0.0162.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0347 between high and low, or 266.92%. For the last week, the stock has had daily average volatility of 318.68%.

Our recommended stop-loss: $0.0192 (-3.82%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (SABSW) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Sab Biotherapeutics, Inc. to open at $0.0269, and during the day (based on 14 day Average True Range), to move between $0.0070 and $0.0330, which gives a possible trading interval of +/-$0.0260 (+/-369.85%) up or down from last closing price. If Sab Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 369.85% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0208 (4.00%) than the support at $0.0168 (16.00%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Sab Biotherapeutics, Inc. stock A Buy?

Sab Biotherapeutics, Inc. holds several positive signals and despite the stock being in a falling trend, we considered it to be a good choice at these current levels. We expect Sab Biotherapeutics, Inc. stock will perform very well in the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 5.909 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $0.0269 ( 34.50%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk